scPharmaceuticals's market cap is currently $168.13M. The company's EPS TTM is $-1.91; its P/E ratio is ―; scPharmaceuticals is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 13.59M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 9.78M	$ -468.00K	$ -438.00K	$ -399.00K	$ -364.00K
Operating Income	$ -55.40M	$ -36.16M	$ -25.82M	$ -29.93M	$ -32.91M
EBITDA	$ -46.06M	$ -33.07M	$ -25.02M	$ -29.22M	$ -30.86M
Net Income	$ -54.81M	$ -37.52M	$ -30.49M	$ -34.39M	$ -34.41M
Balance Sheet
Cash & Short-Term Investments	$ 76.01M	$ 118.37M	$ 75.46M	$ 105.28M	$ 72.81M
Total Assets	$ 94.48M	$ 124.19M	$ 79.04M	$ 109.05M	$ 77.28M
Total Debt	$ 40.27M	$ 37.37M	$ 17.64M	$ 20.21M	$ 20.27M
Net Debt	$ -6.54M	$ -33.69M	$ -56.63M	$ -85.07M	$ -52.54M
Total Liabilities	$ 57.26M	$ 51.76M	$ 22.57M	$ 26.88M	$ 25.92M
Stockholders' Equity	$ 37.22M	$ -226.54M	$ -189.70M	$ -161.66M	$ -129.46M
Cash Flow
Free Cash Flow	$ -59.28M	$ -34.60M	$ -27.16M	$ -27.69M	$ -30.44M
Operating Cash Flow	$ -59.24M	$ -34.58M	$ -27.15M	$ -27.69M	$ -30.44M
Investing Cash Flow	$ 19.96M	$ -45.86M	$ 32.13M	$ -33.46M	$ 0.00
Financing Cash Flow	$ 14.85M	$ 77.23M	$ -2.53M	$ 60.35M	$ 13.59M

Currency in USD

scPharmaceuticals Earnings and Revenue History

Income Statement >

scPharmaceuticals Debt to Assets

Balance Sheet >

scPharmaceuticals Cash Flow

Cash Flow >

scPharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing